Next Generation Drug Delivery & Healthcare Technologies

Pharmachal Health Group is a Melbourne-based pharmaceutical company with a globally-patented, mini-emulsion, drug-in-oil delivery system capable of delivering a wide range of small-molecule APIs (drugs) topically, sublingually, nasally and more. The technology is called the Nano Drug Delivery System (“NDDS”).

​

The NDDS is the only patent-certified, clinically-trialed and approved formulae that releases an active nanoparticle drug, encapsulated in oil, into the blood-stream, targeting a drug specifically to a desired tissue. 

​

The molecular size of NDDS products is an order of magnitude smaller than existing products that dominate billion dollar markets. It presents exceptional opportunities to create new, superior products to deliver existing analgesics, antibiotics, antivirus, oncology, and other small-protein-molecule drugs.

PHG aims to launch its first NDDS product that delivers the common analgesic lidocaine in early 2024.